-
1
-
-
0032152205
-
Epidemiology, risk factors and treatments for antibiotic-associated diarrhea
-
McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 1998;16:292-307.
-
(1998)
Dig Dis
, vol.16
, pp. 292-307
-
-
McFarland, L.V.1
-
2
-
-
84873022582
-
Safety of probiotics used to reduce risk and prevent or treat disease
-
AHRQ Publication No. 11-E007. Agency for Healthcare Research and Quality;. (accessed 5 Jun 2012)
-
Hempel S, Newberry S, Ruelaz A, et al. Safety of probiotics used to reduce risk and prevent or treat disease. Evidence report/technology assessment No. 200. AHRQ Publication No. 11-E007. Agency for Healthcare Research and Quality; 2011. http://www.ahrq.gov/clinic/tp/probiotictp.htm (accessed 5 Jun 2012).
-
(2011)
Evidence Report/technology Assessment No. 200
-
-
Hempel, S.1
Newberry, S.2
Ruelaz, A.3
-
3
-
-
0035129632
-
The effect of oral administration of lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy
-
Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001;15:163-9.
-
(2001)
Aliment Pharmacol Ther
, vol.15
, pp. 163-169
-
-
Armuzzi, A.1
Cremonini, F.2
Bartolozzi, F.3
-
4
-
-
0036840803
-
Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: A parallel group, triple blind, placebo-controlled study
-
Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002;97:2744-9.
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 2744-2749
-
-
Cremonini, F.1
Di Caro, S.2
Covino, M.3
-
5
-
-
10644271912
-
Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: Randomized, double-blind, placebo controlled trial
-
Nista EC, Candelli M, Cremonini F, et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther 2004;20:1181-8.
-
(2004)
Aliment Pharmacol Ther
, vol.20
, pp. 1181-1188
-
-
Nista, E.C.1
Candelli, M.2
Cremonini, F.3
-
6
-
-
67649090385
-
Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy
-
Engelbrektson A, Korzenik JR, Pittler A, et al. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. J Med Microbiol 2009;58(Pt 5):663-70.
-
(2009)
J Med Microbiol
, vol.58
, Issue.PART 5
, pp. 663-670
-
-
Engelbrektson, A.1
Korzenik, J.R.2
Pittler, A.3
-
7
-
-
0026549347
-
Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections
-
Reid G, Bruce AW, Taylor M. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 1992;14:11-16.
-
(1992)
Clin Ther
, vol.14
, pp. 11-16
-
-
Reid, G.1
Bruce, A.W.2
Taylor, M.3
-
8
-
-
84861201441
-
Meta-analysis: Probiotics in antibiotic-associated diarrhoea
-
Videlock EJ, Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2012;35:1355-69.
-
(2012)
Aliment Pharmacol Ther
, vol.35
, pp. 1355-1369
-
-
Videlock, E.J.1
Cremonini, F.2
|